ZFAS1 and chronic myelogenous leukemia, BCR-ABL1 positive: Previously, it is highlighted the role of lncRNAs in cancer progression and drug resistance, but the specific involvement of ZFAS1 in CML resistance mechanisms was not well understood before this study (31).